Is It Too Late to Buy Moderna Stock After Its 127% Surge?
Key Points Moderna has made an incredible comeback, surging sixfold over the past year and by around 127% over the past few weeks. The MRNA vaccine company recently announced promising news that could have major implications for its pivot toward oncology. Yet while the pandemic-era darling has made a comeback, shares could pull back as…